Coston McIsaac & Partners Buys 9,449 Shares of Kimberly-Clark Corporation $KMB

Coston McIsaac & Partners raised its stake in Kimberly-Clark Corporation (NASDAQ:KMB) by 25.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,075 shares of the company’s stock after buying an additional 9,449 shares during the period. Coston McIsaac & Partners’ holdings in Kimberly-Clark were worth $4,444,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of KMB. Godfrey Financial Associates Inc. bought a new position in shares of Kimberly-Clark in the 4th quarter valued at $25,000. Darwin Wealth Management LLC bought a new stake in Kimberly-Clark during the 2nd quarter worth $27,000. CrossGen Wealth LLC acquired a new position in Kimberly-Clark in the 4th quarter worth about $27,000. Eagle Bay Advisors LLC acquired a new position in Kimberly-Clark in the 4th quarter worth about $28,000. Finally, Newbridge Financial Services Group Inc. raised its position in Kimberly-Clark by 96.6% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 285 shares of the company’s stock valued at $29,000 after purchasing an additional 140 shares during the last quarter. Institutional investors own 76.29% of the company’s stock.

Kimberly-Clark Price Performance

Shares of KMB opened at $109.37 on Monday. The company has a market capitalization of $36.30 billion, a PE ratio of 17.17, a PEG ratio of 4.90 and a beta of 0.28. Kimberly-Clark Corporation has a 12 month low of $92.42 and a 12 month high of $137.46. The stock’s 50-day moving average price is $99.34 and its two-hundred day moving average price is $100.79. The company has a current ratio of 0.77, a quick ratio of 0.55 and a debt-to-equity ratio of 3.38.

Kimberly-Clark (NASDAQ:KMB) last issued its quarterly earnings results on Tuesday, April 28th. The company reported $1.97 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.04. Kimberly-Clark had a return on equity of 152.79% and a net margin of 12.80%.The company had revenue of $4.16 billion during the quarter, compared to analysts’ expectations of $4.09 billion. During the same quarter in the prior year, the firm posted $1.93 earnings per share. The business’s quarterly revenue was up 2.7% on a year-over-year basis. On average, analysts anticipate that Kimberly-Clark Corporation will post 7.48 EPS for the current year.

Kimberly-Clark Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 2nd. Shareholders of record on Friday, June 5th will be issued a dividend of $1.28 per share. The ex-dividend date is Friday, June 5th. This represents a $5.12 annualized dividend and a yield of 4.7%. Kimberly-Clark’s dividend payout ratio (DPR) is presently 80.38%.

Insider Buying and Selling

In other news, VP Andrew Scribner sold 4,095 shares of the company’s stock in a transaction on Wednesday, May 6th. The shares were sold at an average price of $98.00, for a total value of $401,310.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Katy Chen sold 1,596 shares of the stock in a transaction on Monday, May 4th. The stock was sold at an average price of $95.34, for a total transaction of $152,162.64. Following the sale, the insider owned 8,362 shares of the company’s stock, valued at approximately $797,233.08. This trade represents a 16.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 7,096 shares of company stock worth $689,687 in the last 90 days. Corporate insiders own 0.75% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. UBS Group lifted their price target on Kimberly-Clark from $105.00 to $106.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Bank of America dropped their price objective on shares of Kimberly-Clark from $130.00 to $120.00 and set a “buy” rating for the company in a report on Friday, April 10th. Zacks Research downgraded shares of Kimberly-Clark from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 3rd. Wells Fargo & Company reduced their target price on shares of Kimberly-Clark from $110.00 to $100.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 8th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Kimberly-Clark in a research report on Wednesday. Four equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Kimberly-Clark presently has a consensus rating of “Hold” and an average price target of $115.43.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.

Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.